2282. Empiric Antimicrobial Therapy and Clinical Outcomes of Infections due to ESBL-producing Klebsiella pneumoniae

BACKGROUND: Currently, carbapenems are the treatment of choice for invasive infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). However, clinical data supporting this practice are generated largely from cases caused by ESBL-producing Escherichia coli. We aimed to de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Wendy Fujita, Ayako, Clarke, Lloyd, Kusztos, Amanda E, Doi, Yohei
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6810055/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.1960
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky